Prior family and adoption studies have suggested a genetic relationship between schizophrenia and schizotypy. However, this has never been verified using linkage methods. We therefore attempted to test for a correlation in linkage signals from genome-wide scans of schizophrenia and schizotypy. The Irish study of high-density schizophrenia families comprises 270 families with at least two members with schizophrenia or poor-outcome schizoaffective disorder (n = 637). Non-psychotic relatives were assessed using the structured interview for schizotypy (n = 746). A 10-cM multipoint, non-parametric, autosomal genomewide scan of schizophrenia was performed in Merlin. A scan of a quantitative trait comprising ratings of DSM-III-R criteria for schizotypal personality disorder in non-psychotic relatives was also performed. Schizotypy logarithm of the odds (LOD) scores were regressed onto schizophrenia LOD scores at all loci, with adjustment for spatial autocorrelation. To assess empirical significance, this was also carried out using 1000 null scans of schizotypy. The number of jointly linked loci in the real data was compared to distribution of jointly linked loci in the null scans. No markers were suggestively linked to schizotypy based on strict LanderKruglyak criteria. Schizotypy LODs predicted schizophrenia LODs above chance expectation genome wide (empirical P = 0.04). Two and four loci yielded nonparametric LOD (NPLs) > 1.0 and > 0.75, respectively, for both schizophrenia and schizotypy (genome-wide empirical P = 0.04 and 0.02, respectively). These results suggest that at least a subset of schizophrenia susceptibility genes also affects schizotypy in non-psychotic relatives. Power may therefore be increased in molecular genetic studies of schizophrenia if they incorporate measures of schizotypy in non-psychotic relatives.
Introduction
Kraepelin, Schneider, Kretschmer and others described domains of personality pathology that aggregate in the relatives of psychotic patients (see Kendler 1 for review). Several such features differentiated the relatives of schizophrenics from those of controls in the Danish adoption studies, and were subsequently incorporated into DSM-III criteria for schizotypal personality disorder (SPD). 2 They include magical thinking, ideas of reference, vague, overelaborate or circumstantial speech, social avoidance, illusions and paranoid ideation.
Considerable evidence from family, 3-7 adoption 8 and twin 9 studies indicates that schizotypal traits are genetically continuous with schizophrenia. However, family studies cannot resolve the effects of genes from common environment. Twin and adoption studies can detect the aggregate effects of many genes, 10 but cannot implicate specific chromosomal regions influencing the liability to two separate phenotypes. To date, no genetic linkage studies of schizotypal traits in exclusively non-psychotic individuals have been published.
Since August 2002, positional cloning methods have succeeded in identifying susceptibility genes for schizophrenia that have subsequently been replicated in additional independent samples, as discussed in several reviews. [11] [12] [13] However, these recent results strongly suggest the presence of allelic or locus heterogeneity in schizophrenia. These sources of genetic complexity, along with potentially others, such as pleiotropy, reduced penetrance, phenocopies and imprinting, may compromise statistical power to detect, identify and/or replicate disease genes. If indeed subclinical traits such as schizotypy are genetically continuous with schizophrenia, analyzing personality and other potential endophenotypes in the unaffected relatives of psychotic subjects may increase statistical power and help resolve inconsistencies.
To date, no genetic linkage studies of schizotypy have been published. In this study, we evaluate a novel approach to clarifying the genetic relationship between schizophrenia and schizotypy, which we call Genome Scan Correlation. This method uses geneticlinkage data to test for a genetic correlation between a disease and an etiologically relevant trait. We performed an autosomal genome-wide scan of schizotypy in non-psychotic relatives in the Irish study of highdensity schizophrenia families (ISHDSF). The resulting linkage statistics from this scan were compared to those from a genome scan of narrowly defined schizophrenia in the same sample. All phenotyped subjects were unique to only one of these two scans.
There are two primary advantages of this method of testing for a genetic correlation. First, this method is not sensitive to the influence of common environment on the familial aggregation of schizophrenia and schizotypy. Environmental bias may be introduced by shared environment in family studies, violations of the equal environment assumption in twin studies and selective placement in adoption studies. Second, it allows the identification of specific chromosomal regions that harbor genes that increase the risk of schizophrenia as well as influence schizotypy. This could provide external support for linkage of these regions to schizophrenia as well as identify regions where schizotypy can be used as an endophenotype in subsequent positional cloning efforts.
Materials and methods

Subjects and assessment
The ISHDSF is a collaborative effort between the Medical College of Virginia of Virginia Commonwealth University, Richmond, the Queen's University, Belfast, and the Health Research Board, Dublin. Fieldwork was carried out between April 1987 and November 1992, as described previously.
14 Interviews were conducted by Irish psychiatrists and social scientists with a background in mental health or survey work after consent was obtained by using procedures approved by the ethical review panels at the Health Research Board and the Queen's University. The original linkage sample consisted of 1425 individuals from 270 families that were ascertained on the basis of having more than one member with DSM-III-R schizophrenia or poor outcome schizoaffective disorder.
Diagnoses were generated using modified sections of the structured interview for DSM-III-R (SCID) for selected axis-I disorders. 15 All relevant diagnostic information for each individual relative was reviewed, blind to pedigree assignment and marker genotypes, independently by KSK and DM. Each diagnostician made up to three best-estimate DSM-III-R diagnoses. Schizotypy was assessed using the structured interview for schizotypy in all subjects without diagnoses of a psychotic disorder. The items used in the schizotypy phenotype comprised a four-level scale for each item of the DSM-III-R criteria for SPD. Importantly, to be included in analysis, subjects were not required to meet criteria for SPD. This is because our hypothesis was that schizotypy is a continuous measure of the genetic liability to schizophrenia, and was not about personality disorder diagnoses per se.
Genotyping
Because of the importance of independent replication, this study was originally designed as a genome scan of three independent sets of 90 Irish multiplex families. A detailed description of the genome-scan strategy has been published. 16 Briefly, a sample of 270 families in which at least two members were affected with psychotic illness was divided into three equal subsets. A total of 684 markers were used, with 488 of these being unique to individual subsets. Average intermarker distances were 9.3, 9.8 and 9.6 cM for the three sets. There were several follow-up regions in which intermarker distance was less, and in which all three subsets were genotyped. These were selected on the basis of scan results in this sample (6p, 5q, 8p and 10p), as well as previous positive results by other groups in schizophrenia (2p, 4q, 5q, 6q, 13q, 18pq) and bipolar disorder (13q and 18q). Markers were predominantly tri-and tetranucleotide repeat microsatellites generated by the Cooperative Human Linkage Center, and many of them are in the Weber screening set, version 8.0. Genotyping methods have been described previously. 17, 18 Linkage analysis We employed genome-wide non-parametric linkage analysis. Two separate genome scans were run: the first used as a phenotype of interest DSM-III-R diagnosis of narrow schizophrenia (schizophrenia or poor-outcome schizoaffective disorder, n = 637 subjects, comprising 537 relative pairs, including 321 sibling pairs). The second used as a quantitative phenotype, the sum of ratings of all DSM-III-R criteria for SPD (mean (s.d.) = 12.27 (3.61), n = 746 subjects, comprising 1481 relative pairs, including 520 sibling pairs). In this second scan, any subject with a diagnosis of any psychotic disorder had a phenotype coded as 'missing'. Therefore, and this is crucial, the sets of subjects whose phenotypes were included in the two scans were entirely non-overlapping.
This QTL method tests for excess allele sharing in relative pairs who are both in the same tail of the trait distribution. It is a non-parametric test that does not require underlying assumptions about the trait distribution. No transformations were used. The S all statistic was calculated using all relative pairs at all available marker phenotypes. NPL-Z scores 19 were calculated in Merlin. 20 Allele frequencies were calculated from pedigree founders only, from the entire sample. Before linkage analysis, all genotypes were checked for non-Mendelian inheritance and excessive recombination events in Merlin using the '-error' option. Erroneous genotypes were removed, per individual, using the Pedwipe program in the Merlin package. We performed three separate linkage analyses for each phenotype: (1) single point, (2) multipoint, at marker positions only and (3) multipoint, with NPL scores calculated at 1-cM intervals throughout the genome. The latter analysis was carried out to rule out the possibility of inflation of LOD scores due to possible inbreeding. 21 We used the '-rsq' option in Merlin to rule out the inflation of linkage statistics due to marker to marker LD. This treats markers that are in LD with each other, as defined by an r 2 threshold, as a 'cluster'. We used a threshold of 0.05, as recently suggested by Levinson and Holmans. 22 Regression and correlation analysis of LOD scores Our purpose was to test for a positive, genome-wide relationship between linkage signals in schizophrenia and schizotypy. A major problem in studying data points that occur along spatial coordinates, in this case, centimorgan position, is the presence of spatial autocorrelation. 23 This is defined as the correlation of a variable's values due to the close physical proximity of individual observations, in this case, NPL scores at adjacent markers. Spatial autocorrelation implies that individual observations are not independent of one another. Non-independence of observations results in underestimation of the error sum of squares in regression analysis. Owing to adjacent loci being in linkage and/or linkage disequilibrium with one another, there will be a positive spatial autocorrelation in the NPL scores of loci on the same chromosome. The closer two loci are, the greater is their correlation. We performed regression analysis using Proc Mixed in SAS. 24 The schizophrenia NPL score was the independent variable, while the schizotypy NPL score was the dependent variable. Spatial autocorrelation was tested and adjusted for. Both SCORING and PARMS options were used, as suggested by Littell and colleagues. 25 In the RE-PEATED statement, we used the options SUBJECT = INTERCEPT, which treats all observations in the data as potentially correlated. The TYPE = SP(SPH) option modeled the spatial covariance between adjacent loci, using a spherical model. The spherical model had a superior fit to the exponential and Gaussian models, as well as a model specifying no spatial correlation, based on the Akaike information criterion.
As this method has not, to our knowledge, been previously used to study genome scan data, we verified the empirical significance of our results by examining the distribution of regression coefficients from 1000 simulated genome scans of schizotypy. For each simulated genome scan, we retained the same genotypes used in the real data, but randomly reassigned schizotypy scores to the same non-psychotic subjects. We opted to simulate trait values rather than marker genotypes. Although it is possible to simulate marker genotypes in Merlin that have the same marker spacing, allele frequencies and pattern of missing values as the real genotypes, it is not currently possible to replicate the same pattern of marker-to-marker linkage or linkage disequilibrium. However, it is precise these factors that produce spatial autocorrelation of linked markers, and which must be invariant across real and simulated scans. Randomization of schizotypy values was carried out without replacement using a random number generator in SAS, and drew from the same pool of schizotypy scores used in the original analyses. Therefore, all simulated scans were based on the same trait distribution, drawn from the same group of subjects, as the original scan. For all simulated scans, NPL scores at all marker positions were regressed onto schizophrenia NPLs, again adjusting for spatial autocorrelation. For this simulation study, all genome scans were multipoint, to maximize power. Scanning was carried out at marker positions only, for the purpose of computational feasibility (SAS runs of Proc Mixed analyzing a single schizotypy-schizophrenia genome scan dyad, using a 1-cM grid, took over 14 h each). Significance was measured by the formula P = (r þ 1)/(n þ 1), where r is the number of simulated genome scans yielding regression coefficients that were equal to or greater than that observed in the real data, and n = 1000 simulated scans. 26 Owing to the novelty of this method, we used a more conservative confirmatory method. To eliminate spatial autocorrelation, we retained only the largest schizotypy NPL score in each 30 centimorgan 'bin'. We then performed correlation analysis between this NPL and the schizophrenia NPL at the same centimorgan position in SAS. As this was a confirmatory test, and we hypothesized a positive correlation between the two NPL scores, a one-tailed test was utilized. Intervals of 30 cM were used for binning following previous practice in genome scan meta-analysis of both bipolar disorder 27 and schizophrenia. 28 Finally, we determined the empirical significance of our results by using the simulated genome scans of schizotypy, described above, to estimate the falsepositive rate of both phenotypes simultaneously yielding linkage signals. First, we determined the number of chromosomal regions at which both schizophrenia and schizotypy resulted in linkage peaks. Owing to the low power of linkage, 29 it is conceivable that true susceptibility genes yield small NPLs. Therefore, we determined a priori NPL thresholds, which were of necessity arbitrary. Then, we determined the number of chromosomes at which each simulated scan achieved the same a priori NPL cutoffs, at the same markers, for both schizophrenia and schizotypy. Two NPL thresholds were used: 1.0 and 0.75. A total of 1000 null scans were used.
Results
Regions with suggestive linkage NPL scores from the 1-cM grid multipoint genome scan of schizophrenia were largely as expected based on previous results. 16 Only two genomic regions, 5q22.1-q31.1 (D5S2501-D5S658, NPL = 3.08) and 8q11. 23 Linkage analysis of schizophrenia and schizotypy using a 1-cM grid The measure of schizotypy employed in this study demonstrated significant heritability, with a siblingpair correlation of 0.22 (P = 0.0001). The NPL curves resulting from multipoint scans of schizophrenia and schizotypy using a 1-cM grid are presented in Figure 1 for chromosomes 5, 9 and 10. Although there were no loci achieving strict Lander-Kruglyak criteria for suggestive linkage to schizotypy, visual inspection of NPL curves for both phenotypes reveals similarity of shape across the genome, as defined by the spatial coincidence of positive and negative deflections, irrespective of magnitude (details available on request). There were several chromosomes in which both phenotypes individually resulted in NPL peaks of 1 or greater, at the same markers. These included the following chromosomal arms (nearest markers): 5q (D5S812-D5S820), 9q (D9S2146-D9S934) and 10p (D10S1423-D10S183). If defined as NPL > 0.8, this would additionally include chromosomes 6p (D6S429), 6q (D6S1007) and 8p (D8S1475). Surprisingly, NPL scores were higher for schizotypy than for schizophrenia on both chromosomes 9q (NPL = 1.72) and 10p (NPL = 1.81).
Regression analysis of NPL scores of schizophrenia and schizotypy When schizotypy NPLs were regressed onto schizophrenia NPLs at all chromosomal locations, with adjustment for spatial correlation, there was a highly significant relationship in multipoint analysis (b = 0.22, nominal P < 0.0001), as well as multipoint analysis using a 1-cM grid (b = 0.16, nominal P < 0.0001), but not in single-point analysis (b = 0.07, nominal P = 0.15). When we performed null genome scans using the same genotypes, but randomly assigned schizotypy scores, we only used multipoint scanning, and at marker positions only, to reduce computational time. These were compared to the multipoint genome scan of the actual data, which was also performed at the marker positions only. Forty of 1000 null scans resulted in a b equal to or greater than that observed in the real data (empirical P = 0.04).
Correlation between schizophrenia and schizotypy NPL scores in 30-cM bins Correlating the highest schizotypy NPL in each 30-cM bin with the schizophrenia NPL at the same position resulted in significant Pearson's product-moment correlations in multipoint analysis using a 1-cM grid (r = 0.23, P = 0.006), single-point analysis (r = 0.22, P = 0.01), and a non-significant trend in the multipoint analysis using marker positions only (r = 0.15, P = 0.06). Regression slopes and correlation coefficients in the latter two sets of analyses are presented in Table 1 . Empirical significance of the number of linkage peaks shared by schizophrenia and schizotypy In the multipoint analyses at marker positions only, two chromosomes in the real data contained markers that yielded NPLs > 1.0 for both schizophrenia and schizotypy at the same markers: 5q22.2 and 16q22.1-q22.1. Forty-two of 1000 simulated scans had two such chromosomes (empirical P = 0.04). At an NPL threshold of 0.75, there were two additional regions: 6q25.3, and 19p13.3, totaling four chromosomes. At this threshold, only 17 null scans contained four or more such chromosomes (empirical P = 0.02).
Discussion
Our hypothesis was that the pattern of linkage findings to schizotypy and schizophrenia would be more similar than would be expected by chance. Using three statistical methods, we observed a significant relationship between NPL scores for these two phenotypes genome wide. These results support previous evidence from family, 3-7 adoption 8 and twin 9 studies that together strongly suggest that schizotypal traits are genetically continuous with schizophrenia.
There is currently a dearth of molecular genetic studies of schizotypy. Only two association studies have been published. One reported an association between the high-activity allele in catechol-O-methyl transferase (COMT), a replicated candidate gene for schizophrenia, 34, 35 with self-reported schizotypy in males. 36 The second study reported association between neuregulin-1 (which also has replicated association to schizophrenia 13 ), and the schizotypy component perceptual aberration, in adolescents. 37 However, several more studies have examined other intermediate phenotypes relevant to the etiology of schizophrenia in non-psychotic individuals. These have mostly examined COMT, and have reported associations between the high-activity allele (Val) and impairments in working memory, 38 attentional control and executive function, 39, 40 as well as abnormalities in P300 40 and mismatch negativity. 41 However, the present report is, to our knowledge, the first genome scan of schizotypal traits in non-psychotic individuals.
The linkage results for schizophrenia were slightly different than what we have reported previously. Almost certainly, this variance is due to differences in analytic methodology. In the genome scan of this sample previously published by Straub et al., 16 three independent family sets were analyzed separately, and were only analyzed together using a fraction of the markers. In the current analyses, we used all available genotypes at all markers simultaneously. Furthermore, in previous studies, chromosomes 6p 16, 33 and 10p 16, 31 yielded considerably greater evidence of linkage using intermediate, broad and very broad definitions of affection, which were not tested here. This was because we were specifically interested in the genetic relationship between schizotypy and narrowly defined illness, which is a stronger hypothesis than the genetic relationship between schizotypy and other spectrum conditions.
Although schizotypy NPL scores were on average lower than those for schizophrenia, the highest schizotypy NPLs we observed when scanning with a 1-cM grid were at regions that have previously been linked to schizophrenia. These include (in order of magnitude) 5q, 28 63 respectively, which were the two genes first identified as susceptibility genes for schizophrenia using positional cloning methods. There are currently no guidelines for replication based on linkage statistics from a non-overlapping subset of subjects from families in the same sample. Nevertheless, given the genome-wide similarity in the pattern of linkage findings for these two phenotypes, and the results of previous linkage studies, this study lends some For the analysis of all marker positions, schizophrenia NPL-Z scores were regressed onto those for schizotypy. For the analyses of the maximum NPL-Z per 30 cM bin, Pearson's product-moment correlations were calculated. Boldface denotes P < 0.05. *Empirical P = 0.04 based on 1000 simulated scans of schizotypy. In these scans, the original genotypes were retained, but schizotypy scores were randomly assigned to the non-psychotic subjects. NPL-Z scores resulting from these scans were used in regression analyses with the results of the original schizophrenia scan.
additional support to chromosomes 5q, 6p, 6q, 8p, 9q and 10p as harboring schizophrenia susceptibility genes. 64 The overall pattern of linkage results for the two phenotypes suggests that schizotypy is probably not as powerful as schizophrenia itself for detecting linkage to susceptibility genes, especially to regions of the genome with lower levels of support. However, in regions with higher a priori probability of harboring susceptibility genes, the incorporation of schizotypy as an endophenotype in gene-finding studies may considerably enhance power. The linkage results also strongly suggest that the significant sibling-pair correlation for schizotypy in non-psychotic relatives in this sample is due in part to genetic, not merely familial, effects. This is the first attempt to test for a genome-wide genetic correlation between a disease and a trait that is thought to be etiologically continuous with it using genotypic data. Genome scan correlation, a new method that we have presented here, could in principle be performed with any two phenotypes. Examples exist of genetic correlations of neuroticism with major depression, [65] [66] [67] generalized anxiety disorder 68 and substance abuse disorders. 69 The results of our study suggest that molecular genetic studies of psychiatric illness would benefit from collecting phenotypic data not only on affected individuals, but on their 'unaffected' relatives as well.
Although there are currently no published genome scans of schizotypy, recently published genome scans of neuroticism 70, 71 and affective illness, 72, 73 suggest a potential overlap of linkage peaks on chromosomes 1q and 12q. Although this is encouraging, it will be necessary to use more rigorous methods to test for a significant similarity in evidence of genetic linkage to neuroticism and major depression, as well as other trait-illness dyads. Future studies of these phenotypes should assess neuroticism in non-depressed relatives, and directly test for a genome-wide relationship between linkage statistics for affective illness and those for neuroticism. This situation differs from that of schizophrenia and schizotypy because the latter faces practical issues due to diagnostic hierarchy. Namely, it is not clinically meaningful to assess schizotypy in patients with psychotic disorders, while it is possible to assess neuroticism in patients with affective illness. Traits that can be measured in the same individual could be used in multivariate linkage analyses. 74 The results of this study should be interpreted in the context of several methodological limitations. First, correlated genome scans can only address the question of whether there is a genetic correlation between two traits. Unlike, for example, twin data, 10 they cannot estimate the magnitude of the genetic correlation. This is because of the low power of linkage to detect true genetic effects. 29 However, with the superior statistical power and information content afforded by much larger samples produced by the pooling of individual samples, 75 as well as highdensity single-nucleotide-polymorphism maps, 76, 77 such estimation may be possible in the future. Second, current statistical methods for correlating genome scan results, such as those we have used in this study, are still in their infancy and have not been tested in additional samples. One complicating factor of these endeavors is that genome scans are often carried out using different sets of markers in different samples. One approach, used in genome scan metaanalysis, 78 attempts to provide evidence for linkage on the basis of the consistency of the ranks of individual genomic regions across samples, irrespective of the absolute magnitude of linkage statistics within samples. This has resulted in evidence for linkage of several chromosomal regions to schizophrenia, despite little evidence supporting these regions in individual studies. 28 Unlike these approaches, we were able to include the actual linkage statistics themselves in analysis, since we were examining the phenotypes of two non-overlapping subsets of the same sample, which were therefore genotyped for the same markers. This allowed us to use a larger array of statistical tests and to confirm the results of one test using another. However, this is the first time that we know of that adjustment for spatial autocorrelation has been used on genome scan data. Nevertheless, linkage statistics have been previously used as variables in other types of statistical analysis. An example is principal components analysis in a study of asthma-related phenotypes. 79 More germane perhaps, is a recent method developed to estimate the correlation between linkage statistics at adjacent map points based on autoregressive models and then use this correlation to estimate study-specific critical values. 80 Clearly, however, much methodological work in this area remains to be carried out.
